Compare VHI & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VHI | MOBI |
|---|---|---|
| Founded | 1932 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.5M | 383.0M |
| IPO Year | 1994 | 2026 |
| Metric | VHI | MOBI |
|---|---|---|
| Price | $15.81 | $11.76 |
| Analyst Decision | Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 10.0K | ★ 84.1K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $2,077,000,000.00 | N/A |
| Revenue This Year | $33.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.12 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.44 | $10.34 |
| 52 Week High | $17.67 | $15.19 |
| Indicator | VHI | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 65.90 | 46.84 |
| Support Level | $12.30 | $10.73 |
| Resistance Level | $17.20 | $12.68 |
| Average True Range (ATR) | 0.82 | 1.01 |
| MACD | 0.18 | 0.07 |
| Stochastic Oscillator | 79.83 | 38.42 |
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.